Navigating the US Regulatory Pathways

Many non-US medical device, diagnostic and pharmaceutical companies have products that would sell well in the United States, but they hesitate to enter the market. These companies market in many countries outside their home nation but don’t cross the US…

Read More

Creating a Roadmap to Commercialization

In today’s medical world where FDA approval is uncertain and investors shy away from risky ventures, a clever invention with incremental advantages over the competition is not enough. Successful innovation must go further than invention to turn good ideas into…

Read More

European Expansion through Partnering

A US based, market leading diagnostics company wanted to expand its product line in Europe where it was a second-tier player. TCG met US and EU managers to define the key search parameters. Through its broad network, TCG identified more…

Read More

Turnaround Strategy

The US subsidiary of a mid-sized Austrian medical device company had been performing poorly for years. TCG conducted a comprehensive analysis of the markets, the subsidiary operations and marketing/sales efforts in all three lines of its US business. Recommendations included…

Read More